Details for 2015742250

Up to date per 04.04.2026

Actions

Title / Product Name

GENETISCHE MARKER ZUR VORHERSAGE DES ANSPRECHENS AUF EINE THERAPIE MIT HDL-ERHÖHUNGS- ODER HDL-NACHAHMUNGSMITTEL

Status

Granted/Registered

Protection Type

European Patent

(AT-) Application Number

2015742250

EP Publication Number

3174995

E-Number

1304001

Language

PCT Number

EP15067098

Publication Date

07.06.2017 A

19.08.2020 B1

Registration Date

19.08.2020

AT Publication Date

15.09.2020

Application Date

27.07.2015

Registration Number

Priorities

30.07.2014

14179048

IPC

C12Q 1/6883 20180101AFI20191211BHEP

Maximum Duration of Protection

27.07.2035

Owner

F. Hoffmann-La Roche AGGrenzacherstrasse 124 4070 BaselCH

Representative

No representatives present

Inventor

DUBÉ, Marie-Pierrec/o Centre de recherche Institut de Cardiologie de Montreal 5000 rue Bélanger Est Bureau S-1430 Montreal H1T 1C8CA

TARDIF, Jean-Claudec/o Montreal Heart Institute 5000 Belanger East street Montreal H1T 1C8CA

Information about Fees